AKT1 is an important signal pathway factor, which participates in all stages of lung cancer occurrence and development [29]; IL-17 can promote angiogenesis through the VEGF pathway, which may indirectly increase the production of NO in the lungs of NSCLC patients and promote the invasion and metastasis of lung cancer [30]. Here, IL17A is linked to non-small cell lung carcinoma.